目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global BRAF kinase inhibitors market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global braf kinase inhibitors market 2018 - 2022 ($ billion)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Dabrafenib - Market size and forecast 2023-2028
Exhibit 34: Chart on Dabrafenib - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Dabrafenib - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Dabrafenib - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Dabrafenib - Year-over-year growth 2023-2028 (%)
6.4 Sorafenib - Market size and forecast 2023-2028
Exhibit 38: Chart on Sorafenib - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Sorafenib - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Sorafenib - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Sorafenib - Year-over-year growth 2023-2028 (%)
6.5 Vemurafenib - Market size and forecast 2023-2028
Exhibit 42: Chart on Vemurafenib - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Vemurafenib - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Vemurafenib - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Vemurafenib - Year-over-year growth 2023-2028 (%)
6.6 Encorafenib - Market size and forecast 2023-2028
Exhibit 46: Chart on Encorafenib - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Encorafenib - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Encorafenib - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Encorafenib - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Product
Exhibit 50: Market opportunity by Product ($ billion)
Exhibit 51: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 52: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 56: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 68: Market opportunity by Distribution Channel ($ billion)
Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Asana BioSciences LLC
Exhibit 119: Asana BioSciences LLC - Overview
Exhibit 120: Asana BioSciences LLC - Product / Service
Exhibit 121: Asana BioSciences LLC - Key offerings
12.4 Bayer AG
Exhibit 122: Bayer AG - Overview
Exhibit 123: Bayer AG - Business segments
Exhibit 124: Bayer AG - Key news
Exhibit 125: Bayer AG - Key offerings
Exhibit 126: Bayer AG - Segment focus
12.5 BeiGene Ltd.
Exhibit 127: BeiGene Ltd. - Overview
Exhibit 128: BeiGene Ltd. - Business segments
Exhibit 129: BeiGene Ltd. - Key offerings
Exhibit 130: BeiGene Ltd. - Segment focus
12.6 Black Diamond Therapeutics Inc.
Exhibit 131: Black Diamond Therapeutics Inc. - Overview
Exhibit 132: Black Diamond Therapeutics Inc. - Product / Service
Exhibit 133: Black Diamond Therapeutics Inc. - Key offerings
12.7 F. Hoffmann La Roche Ltd.
Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
12.8 Fore Biotherapeutics Inc.
Exhibit 139: Fore Biotherapeutics Inc. - Overview
Exhibit 140: Fore Biotherapeutics Inc. - Product / Service
Exhibit 141: Fore Biotherapeutics Inc. - Key offerings
12.9 Jazz Pharmaceuticals Plc
Exhibit 142: Jazz Pharmaceuticals Plc - Overview
Exhibit 143: Jazz Pharmaceuticals Plc - Product / Service
Exhibit 144: Jazz Pharmaceuticals Plc - Key news
Exhibit 145: Jazz Pharmaceuticals Plc - Key offerings
12.10 Kinnate Biopharma
Exhibit 146: Kinnate Biopharma - Overview
Exhibit 147: Kinnate Biopharma - Product / Service
Exhibit 148: Kinnate Biopharma - Key offerings
12.11 Nerviano Medical Sciences S.r.l
Exhibit 149: Nerviano Medical Sciences S.r.l - Overview
Exhibit 150: Nerviano Medical Sciences S.r.l - Product / Service
Exhibit 151: Nerviano Medical Sciences S.r.l - Key offerings
12.12 Novartis AG
Exhibit 152: Novartis AG - Overview
Exhibit 153: Novartis AG - Business segments
Exhibit 154: Novartis AG - Key offerings
Exhibit 155: Novartis AG - Segment focus
12.13 Ono Pharmaceutical Co. Ltd.
Exhibit 156: Ono Pharmaceutical Co. Ltd. - Overview
Exhibit 157: Ono Pharmaceutical Co. Ltd. - Product / Service
Exhibit 158: Ono Pharmaceutical Co. Ltd. - Key offerings
12.14 Pfizer Inc.
Exhibit 159: Pfizer Inc. - Overview
Exhibit 160: Pfizer Inc. - Product / Service
Exhibit 161: Pfizer Inc. - Key news
Exhibit 162: Pfizer Inc. - Key offerings
12.15 Pierre Fabre SA
Exhibit 163: Pierre Fabre SA - Overview
Exhibit 164: Pierre Fabre SA - Business segments
Exhibit 165: Pierre Fabre SA - Key offerings
Exhibit 166: Pierre Fabre SA - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations